Back to Search
DAVID BROWN, MD
MD
Diagnostic Radiology Physician
NPI: 1174580732IndividualAccepts Medicare
Specialties, Licenses & Credentials
Vascular & Interventional Radiology Physician
Radiology — Vascular & Interventional Radiology
Code: 2085R0204X
MD10212(HI)
Diagnostic Ultrasound Physician
Radiology — Diagnostic Ultrasound
Code: 2085U0001X
MD10212(HI)
Nuclear Radiology Physician
Radiology — Nuclear Radiology
Code: 2085N0904X
MD10212(HI)
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
35089928(OH)MD10212(HI)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF HAWAII JOHN A. BURNS SCHOOL OF MEDICINE
Class of 1993
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).
PMID 24518078·Br J Ophthalmol·2014
4-observational
Aflibercept (eylea) for age-related macular degeneration.
PMID 22354219·Med Lett Drugs Ther·2012
6-review
Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration.
PMID 22300011·Expert Opin Pharmacother·2012
6-review
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
PMID 21526923·N Engl J Med·2011
4-observational
Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
PMID 21055816·Ophthalmology·2011
8-other
Vascular endothelial growth factor Trap-Eye for diabetic macular oedema.
PMID 19174397·Br J Ophthalmol·2009
8-other
Predicted biological activity of intravitreal VEGF Trap.
PMID 18356264·Br J Ophthalmol·2008
4-observational
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
PMID 17386270·Am J Ophthalmol·2007
3-trial
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
PMID 17021319·N Engl J Med·2006
4-observational
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
PMID 16458968·Ophthalmology·2006
5-case
Cystoid macular degeneration in chronic central serous chorioretinopathy.
PMID 12652224·Retina·2003
8-other
VEGF-Trap: a VEGF blocker with potent antitumor effects.
PMID 12177445·Proc Natl Acad Sci U S A·2002
7-preclinical
Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
PMID 11927845·Retina·2002
3-trial
Assessment of operative competency in otolaryngology residency: Survey of US Program Directors.
PMID 18641530·Laryngoscope·2008
8-other
Electrodiagnostic medicine skills competency in physical medicine and rehabilitation residents: a method for development and assessment.
PMID 18388558·Am J Phys Med Rehabil·2008
8-other
Amidinate-carboxylate complexes of dimolybdenum and ditungsten: M2(O2CR)2((NiPr)2CR')2. Preparations, molecular and electronic structures and reactions.
PMID 18335145·Dalton Trans·2008
8-other
Effects of 4'-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart.
PMID 18304929·Cardiovasc Res·2008
7-preclinical
Substitution chemistry of MM quadruply bonded complexes (M = Mo or W) supported by the anion of 2-hydroxy-6-methylpyridine.
PMID 17471374·Dalton Trans·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (216) 448-0621
Quick Facts
- NPI
- 1174580732
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 5
- Locations
- 1
- Years in Practice
- 33
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile